Search

everythinglearnresearchcommunity

for

Search:↓

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

The side gland of Suncus murinus is a good model for studying human sebaceous glands.

ERG increases SOX9, promoting prostate cancer growth and invasion.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Markers help differentiate between apocrine and eccrine sweat glands to identify sweat gland tumors.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Acne treatment with isotretinoin increases the presence of p53, a protein, in skin and oil glands, which may help reduce acne severity.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.